Cannabis Bioscience International Holdings (CBIH) Equity Average (2023 - 2026)
Cannabis Bioscience International Holdings' Equity Average history spans 4 years, with the latest figure at -$1.4 million for Q1 2026.
- On a quarterly basis, Equity Average fell 19.91% to -$1.4 million in Q1 2026 year-over-year; TTM through Feb 2026 was -$1.4 million, a 19.91% decrease, with the full-year FY2025 number at -$1.1 million, down 34.23% from a year prior.
- Equity Average hit -$1.4 million in Q1 2026 for Cannabis Bioscience International Holdings, down from -$1.3 million in the prior quarter.
- Over the last five years, Equity Average for CBIH hit a ceiling of -$443479.5 in Q1 2023 and a floor of -$1.4 million in Q1 2026.
- Historically, Equity Average has averaged -$985595.0 across 4 years, with a median of -$1.1 million in 2024.
- Biggest five-year swings in Equity Average: crashed 104.97% in 2024 and later decreased 12.91% in 2025.
- Tracing CBIH's Equity Average over 4 years: stood at -$779673.0 in 2023, then tumbled by 40.45% to -$1.1 million in 2024, then decreased by 19.14% to -$1.3 million in 2025, then fell by 8.47% to -$1.4 million in 2026.
- Business Quant data shows Equity Average for CBIH at -$1.4 million in Q1 2026, -$1.3 million in Q4 2025, and -$1.2 million in Q3 2025.